Literature DB >> 15950078

Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients.

Fatemeh Astaneie1, Mojgan Afshari, Alireza Mojtahedi, Sara Mostafalou, Mohammad Jafar Zamani, Bagher Larijani, Mohammad Abdollahi.   

Abstract

BACKGROUND: The aim of this study was to examine how type 1 diabetic patients have altered levels of lipid peroxidation, antioxidant defense, NO and EGF in their plasma and saliva. We tested the differences in lipid peroxidation level, antioxidant power, and concentrations of epidermal growth factor (EGF) and nitric oxide (NO) in saliva and blood of type 1 diabetic subjects in comparison to healthy control subjects.
METHODS: Nineteen subjects with type 1 diabetes mellitus and 19 healthy age- and sex-matched control subjects were included in the study. Blood and saliva samples were obtained and analyzed for thiobarbituric reactive substances (TBARS) as a marker of lipid peroxidation, ferric reducing ability (total antioxidant power), EGF and NO levels.
RESULTS: TBARS levels did not show a significant difference between the two groups. Analysis of antioxidant power revealed that saliva and plasma of diabetic patients had more antioxidant power (p <0.01) than the healthy control population (107 +/- 10.35 vs. 11.14 +/- 4.66 and 192 +/- 12.3 vs. 142 +/- 15.2 mmol/L, respectively). Concentration of EGF was increased (p <0.01) in saliva whereas it was reduced (p <0.01) in plasma of diabetic patients in comparison to those of healthy subjects (2423 +/- 322 vs. 1513 +/- 341 and 125 +/- 14 vs. 346 +/- 60 pg/mL, respectively). NO level increased in both saliva and plasma of diabetic patients in comparison to those of healthy subjects (46.61 +/- 7 vs. 72.89 +/- 13 and 62.11 +/- 4.6 vs. 76.25 +/- 5 micromol/L, respectively). Blood HbA1c (%) of patients was significantly higher than that of controls (8.3 +/- 0.32 vs. 5.4 +/- 0.24, p <0.01).
CONCLUSIONS: Existence of increased total antioxidant power in the presence of normal lipid peroxidation in plasma and saliva of type 1 diabetic patients indicates the existence of oxidative stress. Increased salivary EGF and NO levels in association with elevated TAOP is interesting and should be further studied.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950078     DOI: 10.1016/j.arcmed.2005.03.007

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  37 in total

Review 1.  Islet transplantation and antioxidant management: a comprehensive review.

Authors:  Seyed Sajad Mohseni Salehi Monfared; Bagher Larijani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

2.  Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes.

Authors:  Sahar K Hegazy; Osama A Tolba; Tarek M Mostafa; Manal A Eid; Dalia R El-Afify
Journal:  Rev Diabet Stud       Date:  2013-05-10

3.  Phosalone-induced inflammation and oxidative stress in the colon: Evaluation and treatment.

Authors:  Seyedeh Farnaz Ghasemi-Niri; Faheem Maqbool; Maryam Baeeri; Mahdi Gholami; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

4.  Biochemical and cellular evidence of the benefit of a combination of cerium oxide nanoparticles and selenium to diabetic rats.

Authors:  Nazila Pourkhalili; Asieh Hosseini; Amir Nili-Ahmadabadi; Shokoufeh Hassani; Mohsen Pakzad; Maryam Baeeri; Azadeh Mohammadirad; Mohammad Abdollahi
Journal:  World J Diabetes       Date:  2011-11-15

5.  Multiple protective mechanisms of alpha-lipoic acid in oxidation, apoptosis and inflammation against hydrogen peroxide induced toxicity in human lymphocytes.

Authors:  Mahban Rahimifard; Mona Navaei-Nigjeh; Maryam Baeeri; Faheem Maqbool; Mohammad Abdollahi
Journal:  Mol Cell Biochem       Date:  2015-02-12       Impact factor: 3.396

6.  Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy.

Authors:  Asieh Hosseini; Mohammad Sharifzadeh; Seyed Mahdi Rezayat; Gholamreza Hassanzadeh; Shokoufeh Hassani; Maryam Baeeri; Vahid Shetab-Bushehri; Dmitry A Kuznetsov; Mohammad Abdollahi
Journal:  Int J Nanomedicine       Date:  2010-08-09

Review 7.  The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae).

Authors:  I E Cock
Journal:  Inflammopharmacology       Date:  2015-07-31       Impact factor: 4.473

8.  Acute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males.

Authors:  Stacy R Oliver; Rebecca L Flores; Andria M Pontello; Jaime S Rosa; Frank P Zaldivar; Pietro R Galassetti
Journal:  J Investig Med       Date:  2008-10       Impact factor: 2.895

Review 9.  Redox changes in obesity, metabolic syndrome, and diabetes.

Authors:  Bato Korac; Andjelika Kalezic; Vanja Pekovic-Vaughan; Aleksandra Korac; Aleksandra Jankovic
Journal:  Redox Biol       Date:  2021-02-04       Impact factor: 11.799

10.  Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial.

Authors:  Sanaz Vosough-Ghanbari; Roja Rahimi; Shabnam Kharabaf; Shima Zeinali; Azadeh Mohammadirad; Somayeh Amini; Nargues Yasa; Alinazar Salehnia; Tayebeh Toliat; Shekoufeh Nikfar; Bagher Larijani; Mohammad Abdollahi
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.